AKRO Message Board Post 10057430 | Akero Therapeutics Inc.
home / stock / akro / akro message board
Thenny52
(investorshub)
Posted on: Dec/23/2022 13:12:24
Source: investorshub
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=170772070
Akero Therapeutics Completes Enrollment of Phase 2b SYMMETRY
News, Short Squeeze, Breakout and More Instantly...
Akero Therapeutics Inc. Company Name:
AKRO Stock Symbol:
Market:
-
SOUTH SAN FRANCISCO, Calif., April 30, 2024 (GLOBE NEWSWIRE) -- Akero Therapeutics, Inc. (Nasdaq: AKRO), a clinical-stage company developing transformational treatments for patients with serious metabolic disease, today announced the appointment of Scott Gangloff as Chief Technology Officer. ...
-
LOS ANGELES, April 28, 2024 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class...
-
(NewsDirect) Investors are making a lot of money on obesity plays. Obesity is at epidemic proportions, so it's easy to see why obesity drugs including GLP-1 agonists have exploded in the marketplace. This class of drugs was originally designed to manage blood sugar levels in diabetics but was...